IL-10RB rs2834167 (A/G) Polymorphism Is Associated with the Susceptibility to Systemic Lupus Erythematosus: Evidence from a Study in Chinese Han Population

[1]  Y. Lee,et al.  Associations between interleukin-10 polymorphisms and susceptibility to systemic lupus erythematosus: a meta-analysis. , 2013, Human immunology.

[2]  D. Ye,et al.  Association of the interleukin-10 gene polymorphism (–1082A/G) with systemic lupus erythematosus: a meta-analysis , 2013, Lupus.

[3]  Dong Hwan Kim,et al.  Association between IL10, IL10RA, and IL10RB SNPs and ischemic stroke with hypertension in Korean population , 2012, Molecular Biology Reports.

[4]  N. Das,et al.  Cytokine imbalance in systemic lupus erythematosus: a study on northern Indian subjects , 2012, Lupus.

[5]  A. Sawalha,et al.  The role of epigenetic variation in the pathogenesis of systemic lupus erythematosus , 2011, Arthritis research & therapy.

[6]  Jun Li,et al.  Genetic variation in IL28RA is associated with the outcomes of HCV infection in a high-risk Chinese population. , 2011, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[7]  S. Rutz,et al.  Regulation and functions of the IL-10 family of cytokines in inflammation and disease. , 2011, Annual review of immunology.

[8]  Annette Lee,et al.  Differential Genetic Associations for Systemic Lupus Erythematosus Based on Anti–dsDNA Autoantibody Production , 2011, PLoS genetics.

[9]  L. Ivashkiv,et al.  Systemic lupus erythematosus monocytes are less responsive to interleukin-10 in the presence of immune complexes. , 2011, Arthritis and rheumatism.

[10]  Gerald McGwin,et al.  A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus , 2009, Nature Genetics.

[11]  Ying Wang,et al.  Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus , 2009, Nature Genetics.

[12]  F. Xiao,et al.  Association between the PD1.3A/G polymorphism of the PDCD1 gene and systemic lupus erythematosus in European populations: a meta‐analysis , 2009, Journal of the European Academy of Dermatology and Venereology : JEADV.

[13]  M. Fujimoto,et al.  Association of IL-10 receptor 2 (IL10RB) SNP with systemic sclerosis. , 2008, Biochemical and biophysical research communications.

[14]  Shizhong Han,et al.  Common Variants within MECP2 Confer Risk of Systemic Lupus Erythematosus , 2008, PloS one.

[15]  G. Hughes,et al.  Systemic lupus erythematosus , 2001, The Lancet.

[16]  Raymond P Donnelly,et al.  Conformational Changes Mediate Interleukin-10 Receptor 2 (IL-10R2) Binding to IL-10 and Assembly of the Signaling Complex* , 2006, Journal of Biological Chemistry.

[17]  H. Whittle,et al.  Class II cytokine receptor gene cluster is a major locus for hepatitis B persistence. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[18]  D. D'cruz.  Systemic lupus erythematosus , 2006, BMJ : British Medical Journal.

[19]  L. Zhao,et al.  Genetic variation in the IL-10 pathway modulates severity of acute graft-versus-host disease following hematopoietic cell transplantation: synergism between IL-10 genotype of patient and IL-10 receptor beta genotype of donor. , 2005, Blood.

[20]  J. Harley,et al.  Polymorphisms of complement receptor 1 and interleukin-10 genes and systemic lupus erythematosus: a meta-analysis , 2005, Human Genetics.

[21]  H. Volk,et al.  The expression of legumain, an asparaginyl endopeptidase that controls antigen processing, is reduced in endotoxin-tolerant monocytes , 2005, Genes and Immunity.

[22]  K. Asadullah,et al.  Is there an interaction between interleukin-10 and interleukin-22? , 2005, Genes and Immunity.

[23]  S. Kotenko,et al.  The expanded family of class II cytokines that share the IL‐10 receptor‐2 (IL‐10R2) chain , 2004, Journal of leukocyte biology.

[24]  N. Logsdon,et al.  Crystal structure of the IL-10/IL-10R1 complex reveals a shared receptor binding site. , 2001, Immunity.

[25]  R. Coffman,et al.  Interleukin-10 and the interleukin-10 receptor. , 2001, Annual review of immunology.

[26]  A. Csiszar,et al.  Increased interferon‐gamma (IFN‐γ), IL‐10 and decreased IL‐4 mRNA expression in peripheral blood mononuclear cells (PBMC) from patients with systemic lupus erythematosus (SLE) , 2000, Clinical and experimental immunology.

[27]  S. Pestka,et al.  Jak-Stat signal transduction pathway through the eyes of cytokine class II receptor complexes , 2000, Oncogene.

[28]  H. Dickensheets,et al.  The interleukin-10 signal transduction pathway and regulation of gene expression in mononuclear phagocytes. , 1999, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[29]  M. Hochberg,et al.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. , 1997, Arthritis and rheumatism.

[30]  M. Fujimoto,et al.  Elevated serum levels of interleukin 4 (IL-4), IL-10, and IL-13 in patients with systemic sclerosis. , 1997, The Journal of rheumatology.